login
  Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

The use of vascular robotic systems for PCI


Monday, 17 Feb 2014 12:37
Ronald P Caputo
Ronald P Caputo

By Ronald P Caputo


The aim of a vascular robotic system is to help interventional cardiologists perform percutaneous coronary intervention (PCI) procedures with greater precision. The systems are designed to provide greater accuracy of lesion measurement, aid in better advancement of guidewires, and help ensure correct placement of stents—which, all together, can lead to less instances of additional stent placement per lesion. For example, robotic systems allow for sub-millimetre movements to place stents and balloons, and can advance or retract guide wires with movements as small as a millimetre.


The precision afforded by these capabilities is greater than what can be achieved manually or using only visual estimates. Potentially, these subtle movements could mean the difference between a successful cardiac catheterisation procedure and one that requires secondary stent placement or a second procedure at a later date due to restenosis. Greater precision in stent placement is certainly warranted—using traditional PCI methods, up to 47% of stents longitudinal geographic miss using traditional methods1. These procedure variations can have a big impact on the incidence of target vessel revascularisation.


With a robotic system, the interventional cardiologist performs the PCI procedure from a “cockpit” rather than being next to the patient. The cockpit contains displays to visualise the procedure, and provides controls for the physician to manipulate the movement of interventional devices such as the guidewire and balloon/stent catheters via the bedside-mounted robotic arm. In my experience, I have found that performing PCI procedures from the cockpit also reduces physical fatigue from standing and leaning over the patient during the procedure.


Additionally, the cockpit’s radiation shielding eliminates the need for physicians to wear the heavy and cumbersome lead aprons used in traditional PCI procedures to protect against radiation exposure. Furthermore, the location of the cockpit in the cath lab provides radiation protection because it is positioned several feet away from the patient and the fluoroscopy unit (but is close enough to enable verbal contact between the patient and staff). The PRECISE study (sponsored by Corindus Vascular Robotics), released in April of 2013, showed that radiation exposure for the physician was reduced by 95.3% from traditional manual procedures; for patients, a reduction in radiation is afforded by the robot by a shortened procedure length. Personally, I welcome the introduction of a technology that will allow us to remove the threat of radiation during every procedure.


I have found that patients are comfortable with the increasing amount of technology that is used in care delivery, and are open to the use of vascular robotic systems provided they are informed about how they are used as well as the benefits they will receive from it. Because of the benefits brought by robotic assistance, I envision that the use of vascular robotic systems will expand into other cardiac procedures (eg. chronic total coronary occlusion, peripheral vascular disease and structural heart conditions) due to the increased level of precision that is offered. However, the key to increased industry acceptance and expansion of use lies with the level of commitment from the full cardiac catheterisation team: a commitment must be made to learning a new skill, training effectively and consistently using the technology.


Ronald P Caputo, interventional cardiologist, St. Joseph’s Hospital Health Centre, Syracuse, USA


Reference

1. Costa, MA. Am J Cardiol 2008; 101: 1704–11




Add New Comment

Most popular


First patient enrolled in Vessix sham-controlled study
Friday, 17 Apr 2015
Boston Scientific has announced that it is taking a new approach to evaluate the performance of its Vessix renal Denervation System. It says it is initiating a study with a novel design to isolate ... First patient enrolled in Vessix sham-controlled study

CardioCel to feature at prominent heart valve conferences
Wednesday, 01 Apr 2015
Admedus’ CardioCel will be featured in a number of presentations at the American Association for Thoracic Surgery Mitral Conclave 2015 meeting and the 95th AATS Annual Meeting. CardioCel to feature at prominent heart valve conferences

Medtronic initiates study evaluating potential of combination of pulmonary vein isolation and renal denervation for atrial fibrillation
Friday, 01 May 2015
Medtronic has announced the start of a clinical study using Medtronic technologies to determine whether paroxysmal and persistent atrial fibrillation can be treated with a combination of two ablation ... Medtronic initiates study evaluating potential of combination of pulmonary vein isolation and renal denervation for atrial fibrillation

Features


Tips and tricks for achieving optimum results with a drug-coated balloon
Thursday, 07 May 2015
With drug-coated balloons, we may have been able to deliver a device to the lesion, but we were not always sure how much drug we actually delivered. Fortunately, because of this problem, there have ... Tips and tricks for achieving optimum results with a drug-coated balloon

Robotic PCI could be used to reduce radiation exposure to the operator
Thursday, 09 Apr 2015
Ryan Madder, an interventional cardiologist at the Frederik Meijer Heart & Vascular Institute (Spectrum Health, Grand Rapids, Michigan, USA) explains why he believes a robotic system (CorPath, C... Robotic PCI could be used to reduce radiation exposure to the operator

Profiles


Flavio Ribichini
Thursday, 05 Mar 2015
Flavio Ribichini speaks to Cardiovascular News about being involved in the first use of primary ... Flavio Ribichini

Sunil Rao
Thursday, 23 Oct 2014
Sunil Rao speaks to Cardiovascular News about his career highlights, including his research into ... Sunil Rao

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions